YUKI GOSEI KOGYO CO.,LTD. (4531) Stock Price

Organic Synthesis Chemicals Industry manufactures and sells amino acids, chemical products, and pharmaceuticals as its primary business. The company operates as a single segment in the fine chemicals business.

In the amino acids segment, Organic Synthesis Chemicals Industry manufactures and sells amino acids and vitamin raw materials. This contributes to the health food and nutritional supplement markets.

In the chemical products segment, the company manufactures and sells tire cord adhesive raw materials, agricultural chemical intermediates, and silicon compounds. This serves demand in the automotive and agricultural industries.

In the pharmaceuticals segment, Organic Synthesis Chemicals Industry manufactures and sells pharmaceutical raw materials and intermediates. This positions the company as an important supplier to the pharmaceutical industry.

Additionally, its subsidiary Yuki Techno Service Co., Ltd. primarily provides contract manufacturing services for Organic Synthesis Chemicals Industry. This subsidiary is classified as a non-consolidated subsidiary.

Organic Synthesis Pharmaceutical Industries operates under the management philosophy of "creating products that benefit people and bring them joy." Based on this philosophy, the company focuses on fine chemicals business and pursues manufacturing excellence by combining technology and expertise. Through this approach, the company aims to enhance corporate value for all stakeholders, including shareholders, customers, employees, and local communities.

The company has formulated a three-year medium-term management plan beginning with the fiscal year ending March 2024. This plan aims to build a growth foundation for the next decade through expanding sales of core products and continuously introducing new products. The company is committed to improving profitability even in a fluctuating economic environment.

Key initiatives in the new medium-term management plan include fostering a quality culture, enhancing corporate value, restructuring the amino acids business, expanding contract manufacturing in the pharmaceutical sector, and expanding and restructuring the chemical products business. Through these measures, the company pursues sustainable growth.

Organic Synthesis Pharmaceutical Industries has set management targets including revenue, operating profit, ordinary profit, net income, and ROA. The company aims to enhance corporate value through achieving these targets, with particular emphasis on improving profitability and operational efficiency.